Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

D. Wetterskog · SciRah

Researcher profile · Semantic Scholar

D. Wetterskog

Share profile

D. Wetterskog — researcher profile on SciRah

h-index: 28
Works: 86
Citations: 3,396

Most-cited papers

Plasma AR and abiraterone-resistant prostate cancer
A. Romanel, Delila Gasi Tandefelt, V. Conteduca, A. Jayaram +19 more
2015Science Translational Medicine455 citations Open access
Semantic Scholar
Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis.
L. Nissen, Ren-Hai Cao, E. Hedlund, Zong-Wei Wang +5 more
2007Journal of Clinical Investigation299 citations Open access
Semantic Scholar
Emerging therapeutic targets in endometrial cancer
K. Dedes, D. Wetterskog, A. Ashworth, S. Kaye +1 more
2011Nature Reviews Clinical Oncology280 citations
Semantic Scholar
PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
K. Dedes, D. Wetterskog, A. Mendes-Pereira, R. Natrajan +8 more
2010Science Translational Medicine271 citations Open access
Semantic Scholar
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study
V. Conteduca, D. Wetterskog, M. Sharabiani, E. Grande +29 more
2017Annals of Oncology261 citations Open access
Semantic Scholar
Synthetic lethality of PARP inhibition in cancers lacking BRCA1 and BRCA2 mutations
K. Dedes, P. Wilkerson, D. Wetterskog, B. Weigelt +2 more
2011Cell Cycle202 citations Open access
Semantic Scholar
Adenoid cystic carcinomas constitute a genomically distinct subgroup of triple‐negative and basal‐like breast cancers
D. Wetterskog, M. Á. López-García, M. Lambros, R. A'Hern +13 more
2012Journal of Pathology160 citations
Semantic Scholar
Functional Viability Profiles of Breast Cancer
R. Brough, J. Frankum, D. Sims, A. Mackay +18 more
2011Cancer Discovery154 citations Open access
Semantic Scholar
Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse
S. Taavitsainen, N. Engedal, S. Cao, F. Handle +29 more
2021Nature Communications103 citations Open access
Semantic Scholar
Blood-based liquid biopsies for prostate cancer: clinical opportunities and challenges
B. Trujillo, A. Wu, D. Wetterskog, G. Attard
2022British Journal of Cancer99 citations Open access
Semantic Scholar
Functional characterization of the 19q12 amplicon in grade III breast cancers
R. Natrajan, A. Mackay, P. Wilkerson, M. Lambros +12 more
2012Breast Cancer Research81 citations Open access
Semantic Scholar
Genome-wide plasma DNA methylation features of metastatic prostate cancer
A. Wu, P. Cremaschi, D. Wetterskog, V. Conteduca +16 more
2020Journal of Clinical Investigation79 citations Open access
Semantic Scholar
Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer
V. Conteduca, A. Jayaram, N. Romero-Laorden, D. Wetterskog +24 more
2019European Urology77 citations Open access
Semantic Scholar
Loss of redness (a*) as a tool to follow hemoglobin-mediated lipid oxidation in washed cod mince.
D. Wetterskog, I. Undeland
2004Journal of Agricultural and Food Chemistry65 citations
Semantic Scholar
Plasma tumor gene conversions after one cycle abiraterone acetate for metastatic castration-resistant prostate cancer: a biomarker analysis of a multi-center international trial.
A. Jayaram, A. Wingate, D. Wetterskog, G. Wheeler +14 more
2021Annals of Oncology59 citations Open access
Semantic Scholar
Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers
D. Wetterskog, K.-K. Shiu, I. Chong, T. Meijer +6 more
2014Oncogene48 citations
Semantic Scholar
Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test
E. González-Billalabeitia, V. Conteduca, D. Wetterskog, A. Jayaram +1 more
2018Prostate Cancer and Prostatic Diseases45 citations Open access
Semantic Scholar
Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations
D. Wetterskog, P. Wilkerson, D. Rodrigues, M. Lambros +15 more
2013Histopathology41 citations Open access
Semantic Scholar
Functional characterization of EMSY gene amplification in human cancers
P. Wilkerson, K. Dedes, D. Wetterskog, A. Mackay +7 more
2011Journal of Pathology37 citations Open access
Semantic Scholar
LOXL2 induces aberrant acinar morphogenesis via ErbB2 signaling
Joan Chang, M. Nicolau, T. Cox, D. Wetterskog +3 more
2013Breast Cancer Research35 citations Open access
Semantic Scholar
Cortactin gene amplification and expression in breast cancer: a chromogenic in situ hybridisation and immunohistochemical study
K. Dedes, M. López-García, F. Geyer, M. Lambros +7 more
2010Breast Cancer Research and Treatment35 citations Open access
Semantic Scholar
Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers.
E. Grist, P. Dutey-Magni, Marina A. Parry, L. Mendes +43 more
2025Cell34 citations Open access
Semantic Scholar
Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis.
A. Jayaram, A. Wingate, D. Wetterskog, V. Conteduca +26 more
2019JCO Precision Oncology34 citations Open access
Semantic Scholar
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer
V. Conteduca, D. Wetterskog, E. Scarpi, A. Romanel +13 more
2020British Journal of Cancer33 citations Open access
Semantic Scholar
Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer.
V. Conteduca, E. Castro, D. Wetterskog, E. Scarpi +20 more
2019European Journal of Cancer29 citations
Semantic Scholar
p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF β-receptor
H. Uramoto, D. Wetterskog, A. Hackzell, Yoshiki Matsumoto +1 more
2004Journal of Cell Science29 citations Open access
Semantic Scholar
External validation of a digital pathology-based multimodal artificial intelligence-derived prognostic model in patients with advanced prostate cancer starting long-term androgen deprivation therapy: a post-hoc ancillary biomarker study of four phase 3 randomised controlled trials of the STAMPEDE pl
C. Parker, L. Mendes, V. Liu, E. Grist +36 more
2025The Lancet Digital Health28 citations Open access
Semantic Scholar
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies
K. Shiu, D. Wetterskog, A. Mackay, R. Natrajan +14 more
2014Oncogene28 citations Open access
Semantic Scholar
Accumulation of copy number alterations and clinical progression across advanced prostate cancer
E. Grist, S. Friedrich, C. Brawley, L. Mendes +28 more
2022Genome Medicine27 citations Open access
Semantic Scholar
Plasma androgen receptor and serum chromogranin A in advanced prostate cancer
V. Conteduca, E. Scarpi, S. Salvi, V. Casadio +11 more
2018Scientific Reports26 citations Open access
Semantic Scholar
Kinetics of repression by modified p53 on the PDGF β‐receptor promoter
Weiwen Yang, D. Wetterskog, Yoshiki Matsumoto, K. Funa
2008International Journal of Cancer21 citations Open access
Semantic Scholar
pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF β-receptor transcription
H. Uramoto, A. Hackzell, D. Wetterskog, A. Ballagi +2 more
2004Journal of Cell Science21 citations Open access
Semantic Scholar
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay
F. Orlando, A. Romanel, B. Trujillo, M. Sigouros +15 more
2022NAR Cancer17 citations Open access
Semantic Scholar
Multimodal Approach to Outcome Prediction in Metastatic Castration-Resistant Prostate Cancer by Integrating Functional Imaging and Plasma DNA Analysis.
V. Conteduca, E. Scarpi, F. Matteucci, P. Caroli +11 more
2019JCO Precision Oncology16 citations Open access
Semantic Scholar
A rabbit helper T cell clone reactive against group-specific streptococcal carbohydrate.
Sharon H. Jackson, T. Folks, D. Wetterskog, T. J. Kindt
1984Journal of Immunology16 citations
Semantic Scholar
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial.
M. Ruiz-Vico, D. Wetterskog, F. Orlando, S. Thakali +25 more
2024European Urology Oncology15 citations Open access
Semantic Scholar
Clinical testing of transcriptome-wide expression profiles in high-risk localized and metastatic prostate cancer starting androgen deprivation therapy: an ancillary study of the STAMPEDE abiraterone Phase 3 trial
M. Parry, E. Grist, L. Mendes, P. Dutey-Magni +42 more
2023Research Square14 citations Open access
Semantic Scholar
Circulating Androgen Receptor for Prognosis and Treatment Selection in Prostate Cancer.
V. Conteduca, D. Wetterskog, E. González-Billalabeitia, N. Brighi +2 more
2021European Urology Oncology13 citations
Semantic Scholar
A correlative biomarker study and integrative prognostic model in chemotherapy‐naïve metastatic castration‐resistant prostate cancer treated with enzalutamide
M. P. Fernández-Pérez, E. Pérez-Navarro, T. Alonso-Gordoa, V. Conteduca +27 more
2022The Prostate12 citations Open access
Semantic Scholar
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
A. M. Mahedi Hasan, P. Cremaschi, D. Wetterskog, A. Jayaram +19 more
2023Nature Communications10 citations Open access
Semantic Scholar
Identification of single nucleotide variants using position-specific error estimation in deep sequencing data
D. Kleftogiannis, M. Punta, A. Jayaram, S. Sandhu +6 more
2018BMC Medical Genomics10 citations Open access
Semantic Scholar
Plasma tumor DNA is associated with increased risk of venous thromboembolism in metastatic castration‐resistant cancer patients
V. Conteduca, E. Scarpi, D. Wetterskog, N. Brighi +16 more
2021International Journal of Cancer9 citations
Semantic Scholar
Dysregulation of Platelet-Derived Growth Factor β-Receptor Expression by ΔNp73 in Neuroblastoma
D. Wetterskog, A. Moshiri, T. Ozaki, H. Uramoto +2 more
2009Molecular Cancer Research8 citations Open access
Semantic Scholar
A monoclonal antibody directed against a synthetic peptide reacts with a cell surface rabbit class I MHC molecule.
A. Le Guern, D. Wetterskog, Patrice N. Marche, T. J. Kindt
1987Molecular Immunology8 citations
Semantic Scholar
Plasma DNA and Metastatic Castration-Resistant Prostate Cancer: The Odyssey to a Clinical Biomarker Test.
A. Jayaram, D. Wetterskog, G. Attard
2018Cancer Discovery7 citations Open access
Semantic Scholar
Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial.
Gianmarco Leone, F. Orlando, P. Dutey-Magni, O. Vainauskas +17 more
2025JAMA Oncology6 citations Open access
Semantic Scholar
Liquid biopsy identifies taxane resistance and clonal selection in castration-resistant prostate cancer.
N. Brighi, D. Wetterskog, O. Vainauskas, F. Orlando +19 more
2025Clinical Cancer Research6 citations Open access
Semantic Scholar
Plasma androgen receptor and response to adapted and standard docetaxel regimen in castration-resistant prostate cancer: A multicenter biomarker study.
V. Conteduca, D. Wetterskog, E. Castro, E. Scarpi +16 more
2021European Journal of Cancer5 citations
Semantic Scholar
Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study
A. Jayaram, Memuna Rashid, A. Reid, F. Orlando +25 more
2026Nature Cancer3 citations Open access
Semantic Scholar
Prognostic Implications of Blood Immune-Cell Composition in Metastatic Castration-Resistant Prostate Cancer
E. Pérez-Navarro, V. Conteduca, Juan M Funes, José I. Domínguez +29 more
2024Cancers3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Attard×21
Invite
G. Attard — researcher profile on SciRah
A. Wingate×19
Invite
A. Wingate — researcher profile on SciRah
A. Jayaram×16
Invite
A. Jayaram — researcher profile on SciRah
V. Conteduca×15
Invite
V. Conteduca — researcher profile on SciRah

×15

Invite

U. de Giorgi — researcher profile on SciRah

Invite

G. Gurioli — researcher profile on SciRah

E. González-Billalabeitia×11

Invite

E. González-Billalabeitia — researcher profile on SciRah

J. Reis-Filho×10

Invite

J. Reis-Filho — researcher profile on SciRah

Invite

C. Lolli — researcher profile on SciRah

Invite

R. Natrajan — researcher profile on SciRah

Invite

G. Attard — researcher profile on SciRah

Invite

A. Ashworth — researcher profile on SciRah